# Cefepime

NDC: 0338-1301
Generic name: cefepime
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20080805

FDA application: NDA050817

## Active ingredients

- CEFEPIME HYDROCHLORIDE: 1 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-1301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-1301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be5f8ca6-7232-423a-a2d5-cccb7abe7921